Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry.

doi:10.1016/j.atherosclerosis.2026.120691

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry.

Atherosclerosis - 1 Apr 2026

Galimberti Federica, Capra Maria Elena, Olmastroni Elena, Braghiroli Davide, Banderali Giuseppe, Baratta Francesco, Biasucci Giacomo, Biolo Marta, Buonuomo Paola Sabrina, Cefalù Angelo Baldassare, Cipollone Francesco, Citroni Nadia, D'Addato Sergio, Genovesi Simonetta, Guardamagna Ornella, Iughetti Lorenzo, Mandraffino Giuseppe, Minicocci Ilenia, Mombelli Giuliana Germana, Montalcini Tiziana, Nascimbeni Fabio, Passaro Angelina, Pirro Matteo, Rinaldi Elisabetta, Sbrana Francesco, Scicali Roberto, Suppressa Patrizia, Werba Pablo Josè, Zenti Maria Grazia, Arca Marcello, Averna Maurizio, Tarugi Patrizia, Calandra Sebastiano, Catapano Alberico Luigi, Pederiva Cristina, Casula Manuela

Abstract excerpt

BACKGROUND AND AIM: Familial hypercholesterolemia (FH) is a common genetic disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) from early life, significantly increasing lifetime risk of atherosclerotic cardiovascular disease. Early identification and initiation of lipid-lowering therapy (LLT) are crucial. This study aimed to describe the timing, pharmacological approach, and early...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anticholesteremic Agents

Share to Cholesterol, LDL

Share to Drug Therapy, Combination

Share to Ezetimibe

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipoproteinemia Type II

Share to Italy

Share to Registries

Source

Open in PubMed

Identifiers

PMID: 41764820
DOI: 10.1016/j.atherosclerosis.2026.120691

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry.PMID 41764820Read ↗

Knowns and unknowns in the care of pediatric familial hypercholesterolemiaSemantic proximity Read ↗

Lipid Screening, Action, and Follow-up in Children and Adolescents.Semantic proximity Read ↗

Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.Semantic proximity Read ↗

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.Semantic proximity Read ↗

Proposal of a familial hypercholesterolemia paediatric diagnostic score (FH-PeDS).Semantic proximity Read ↗

Population-Based Screening in Children For Early Diagnosis and Treatment of Familial Hypercholesterolemia: Design of The VRONI StudySemantic proximity Read ↗

Simplified Criteria for Identification of Familial Hypercholesterolemia in Children: Application in Real LifeSemantic proximity Read ↗

Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert PanelSemantic proximity Read ↗

Clinical characteristics and lipid management of patients with familial hypercholesterolemia: results from a 7 years single-centre experience.Semantic proximity Read ↗

Familial Hypercholesterolemia: From Clinical Suspicion to Novel TreatmentsSemantic proximity Read ↗

Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis.Semantic proximity Read ↗

Familial hypercholesterolaemia in children and adolescents: a new paediatric model of care.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.